NDC 54828-001

Neuraceq

Florbetaben F 18

Neuraceq is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Life Molecular Imaging, Sa. The primary component is Florbetaben F-18.

Product ID54828-001_0ba79331-febc-4573-97d0-32b7e4c3044f
NDC54828-001
Product TypeHuman Prescription Drug
Proprietary NameNeuraceq
Generic NameFlorbetaben F 18
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2014-03-20
Marketing CategoryNDA / NDA
Application NumberNDA204677
Labeler NameLife Molecular Imaging, SA
Substance NameFLORBETABEN F-18
Active Ingredient Strength135 mCi/mL
Pharm ClassesRadioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 54828-001-30

1 VIAL, MULTI-DOSE in 1 CONTAINER (54828-001-30) > 30 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2014-03-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 54828-001-30 [54828000130]

Neuraceq INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA204677
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-03-20

Drug Details

Active Ingredients

IngredientStrength
FLORBETABEN F-18135 mCi/mL

Pharmacological Class

  • Radioactive Diagnostic Agent [EPC]
  • Positron Emitting Activity [MoA]

Trademark Results [Neuraceq]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NEURACEQ
NEURACEQ
85940455 4822567 Live/Registered
Piramal Imaging S.A.
2013-05-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.